Cell Line : MHH-CALL-4
Cellosaurus Index : CVCL_1410
Cellosaurus ID : MHH-CALL-4
CTRP2 Name
: MHHCALL4
GDSC2 Name
: MHH-CALL-4
CCLE Name
: MHHCALL4_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
Cancer Type : haematopoietic_and_lymphoid_tissue
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| MHH-CALL-4 | 16-beta-bromoandrosterone | CTRP2 | 0.0011 | 37.0000 |
|
| MHH-CALL-4 | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | 3-Cl-AHPC | CTRP2 | 0.0041 | 66.0000 |
|
| MHH-CALL-4 | 5-Fluorouracil | GDSC2 | 0.0200 | 20.0000 |
|
| MHH-CALL-4 | A-804598 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | AA-COCF3 | CTRP2 | 0.0081 | 270.0000 |
|
| MHH-CALL-4 | abiraterone | CTRP2 | 0.0005 | 17.0000 |
|
| MHH-CALL-4 | ABT737 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | AC55649 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | Afatinib | GDSC2 | 0.0040 | 4.0000 |
|
| MHH-CALL-4 | Afuresertib | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | AGI-5198 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | AGI-6780 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | AGK-2 | GDSC2,CTRP2 | 0.0020 | 33.0000 |
|
| MHH-CALL-4 | Alisertib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Alpelisib | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | AM-580 | CTRP2 | 0.0160 | 530.0000 |
|
| MHH-CALL-4 | AMG-319 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | ASN 05257430 | CTRP2 | 0.0011 | 37.0000 |
|
| MHH-CALL-4 | AT-406 | CTRP2 | 0.0320 | 66.0000 |
|
| MHH-CALL-4 | AT13148 | GDSC2 | 0.0080 | 8.0000 |
|
| MHH-CALL-4 | AT7867 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Avagacestat | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | avrainvillamide | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | Axitinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | AZ-3146 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | AZ6102 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | AZ960 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | azacitidine | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | AZD-7545 | CTRP2 | 0.0023 | 74.0000 |
|
| MHH-CALL-4 | AZD3759 | GDSC2 | 0.0010 | 1.0000 |
|
| MHH-CALL-4 | AZD4547 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | AZD5363 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | AZD5582 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | AZD6482 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | AZD6738 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | AZD7762 | GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| MHH-CALL-4 | AZD8055 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | AZD8186 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | bardoxolone methyl | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Bax channel blocker | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | bendamustine | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | betulinic acid | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Bexarotene | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BI-2536 | GDSC2,CTRP2 | 0.0005 | 33.0000 |
|
| MHH-CALL-4 | BIBR-1532 | GDSC2,CTRP2 | 0.0081 | 270.0000 |
|
| MHH-CALL-4 | Bicalutamide | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BIX-01294 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BMS-195614 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BMS-345541 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BMS-536924 | GDSC2,CTRP2 | 0.0011 | 37.0000 |
|
| MHH-CALL-4 | BMS-754807 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | Bortezomib | GDSC2,CTRP2 | 0.0000 | 0.1300 |
|
| MHH-CALL-4 | Bosutinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-A02303741 | CTRP2 | 0.0017 | 55.0000 |
|
| MHH-CALL-4 | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-A02303741:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MHH-CALL-4 | BRD-A71883111 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | BRD-A94377914 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | BRD-K02251932 | CTRP2 | 0.0320 | 66.0000 |
|
| MHH-CALL-4 | BRD-K02492147 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K03536150 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K03911514 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K04800985 | CTRP2 | 0.0081 | 66.0000 |
|
| MHH-CALL-4 | BRD-K07442505 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K09344309 | CTRP2 | 0.0010 | 17.0000 |
|
| MHH-CALL-4 | BRD-K09587429 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K11533227 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K13999467 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K14844214 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K16147474 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K17060750 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K20514654 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K24690302 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| MHH-CALL-4 | BRD-K27188169 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K27188169:navitoclax (2:1 mol-mol) | CTRP2 | 0.0030 | 50.0000 |
|
| MHH-CALL-4 | BRD-K28456706 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K29313308 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K33199242 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K34222889 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K37390332 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | BRD-K41597374 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K45681478 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K50799972 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K52037352 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K55116708 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K55473186 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K61166597 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K63431240 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K64610608 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | BRD-K66453893 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K66532283 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K70511574 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K71781559 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K71935468 | CTRP2 | 0.0025 | 83.0000 |
|
| MHH-CALL-4 | BRD-K79669418 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K80183349 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K85133207 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K88742110 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K92856060 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | BRD-K94991378 | CTRP2 | 0.0025 | 83.0000 |
|
| MHH-CALL-4 | BRD-K97651142 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-K99584050 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD-M00053801 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD1812 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD1835 | CTRP2 | 0.0041 | 130.0000 |
|
| MHH-CALL-4 | BRD4132 | CTRP2 | 0.0049 | 160.0000 |
|
| MHH-CALL-4 | BRD55319 | CTRP2 | 0.0011 | 37.0000 |
|
| MHH-CALL-4 | BRD6340 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | BRD8899 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | BRD8958 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | BRD9647 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | BRD9876 | CTRP2 | 0.0041 | 130.0000 |
|
| MHH-CALL-4 | brefeldin A | CTRP2 | 0.0011 | 37.0000 |
|
| MHH-CALL-4 | brivanib | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Buparlisib | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | BX795 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | C6-ceramide | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Cabozantinib | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Camptothecin | GDSC2 | 0.0001 | 0.1000 |
|
| MHH-CALL-4 | canertinib | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Carboplatin | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | carboplatin:etoposide (40:17 mol-mol) | CTRP2 | 0.0014 | 47.0000 |
|
| MHH-CALL-4 | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MHH-CALL-4 | CAY10576 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | CAY10594 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | CCT-018159 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | CCT007093 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | CCT036477 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | CD-1530 | CTRP2 | 0.0041 | 130.0000 |
|
| MHH-CALL-4 | CD-437 | CTRP2 | 0.0011 | 37.0000 |
|
| MHH-CALL-4 | Cediranib | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | cerulenin | CTRP2 | 0.0045 | 150.0000 |
|
| MHH-CALL-4 | Ch-55 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | CHEMBL1222381 | CTRP2 | 0.0081 | 270.0000 |
|
| MHH-CALL-4 | CHEMBL374350 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | CHIR-99021 | GDSC2,CTRP2 | 0.0024 | 80.0000 |
|
| MHH-CALL-4 | chlorambucil | CTRP2 | 0.0081 | 270.0000 |
|
| MHH-CALL-4 | CHM-1 | CTRP2 | 0.0005 | 16.0000 |
|
| MHH-CALL-4 | CI-976 | CTRP2 | 0.0081 | 270.0000 |
|
| MHH-CALL-4 | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | ciclosporin | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | CIL41 | CTRP2 | 0.0049 | 160.0000 |
|
| MHH-CALL-4 | CIL55 | CTRP2 | 0.0003 | 10.0000 |
|
| MHH-CALL-4 | CIL55A | CTRP2 | 0.0024 | 80.0000 |
|
| MHH-CALL-4 | CIL56 | CTRP2 | 0.0001 | 2.5000 |
|
| MHH-CALL-4 | CIL70 | CTRP2 | 0.0012 | 40.0000 |
|
| MHH-CALL-4 | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | COL-3 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Compound 1541A | CTRP2 | 0.0011 | 37.0000 |
|
| MHH-CALL-4 | compound 1B | CTRP2 | 0.0081 | 66.0000 |
|
| MHH-CALL-4 | Compound 23 citrate | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | Compound 7d-cis | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | Crizotinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | crizotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MHH-CALL-4 | cucurbitacin I | CTRP2 | 0.0010 | 17.0000 |
|
| MHH-CALL-4 | curcumin | CTRP2 | 0.0051 | 170.0000 |
|
| MHH-CALL-4 | cyanoquinoline 11 | CTRP2 | 0.0041 | 130.0000 |
|
| MHH-CALL-4 | Cyclophosphamide | GDSC2,CTRP2 | 0.0041 | 130.0000 |
|
| MHH-CALL-4 | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | cytochalasin B | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | CZC24832 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | Dabrafenib | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | Dacarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Dactinomycin | GDSC2 | 0.0008 | 0.8000 |
|
| MHH-CALL-4 | Dactolisib | GDSC2,CTRP2 | 0.0003 | 17.0000 |
|
| MHH-CALL-4 | Daporinad | GDSC2,CTRP2 | 0.0000 | 2.0000 |
|
| MHH-CALL-4 | darinaparsin | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | Dasatinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | DBeQ | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MHH-CALL-4 | dexamethasone | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | Dinaciclib | GDSC2 | 0.0010 | 1.0000 |
|
| MHH-CALL-4 | Docetaxel | GDSC2 | 0.0000 | 0.0125 |
|
| MHH-CALL-4 | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MHH-CALL-4 | Doramapimod | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Doxorubicin | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0030 | 50.0000 |
|
| MHH-CALL-4 | EHT-1864 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | ELCPK | CTRP2 | 0.0000 | 0.4000 |
|
| MHH-CALL-4 | Elesclomol | GDSC2 | 0.0002 | 0.2000 |
|
| MHH-CALL-4 | elocalcitol | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Entinostat | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Entospletinib | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | epigallocatechin-3-monogallate | CTRP2 | 0.0090 | 300.0000 |
|
| MHH-CALL-4 | Epirubicin | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | EPZ004777 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | EPZ5676 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | erastin | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Erlotinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | erlotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MHH-CALL-4 | etomoxir | CTRP2 | 0.0090 | 300.0000 |
|
| MHH-CALL-4 | Etoposide | CTRP2 | 0.0009 | 28.0000 |
|
| MHH-CALL-4 | ETP-46464 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Fedratinib | CTRP2 | 0.0011 | 37.0000 |
|
| MHH-CALL-4 | fingolimod | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | fluorouracil | CTRP2 | 0.0041 | 130.0000 |
|
| MHH-CALL-4 | fluvastatin | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Foretinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | FQI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | FQI-2 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | Fulvestrant | GDSC2 | 0.0010 | 1.0000 |
|
| MHH-CALL-4 | fumonisin B1 | CTRP2 | 0.0150 | 500.0000 |
|
| MHH-CALL-4 | GANT-61 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | GDC-0879 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | GDC0810 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | Gefitinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Gemcitabine | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | GMX-1778 | CTRP2 | 0.0000 | 0.2900 |
|
| MHH-CALL-4 | GNE-317 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | gossypol | CTRP2 | 0.0011 | 18.0000 |
|
| MHH-CALL-4 | GSK-3 inhibitor IX | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | GSK1059615 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | GSK1904529A | GDSC2 | 0.0050 | 5.0000 |
|
| MHH-CALL-4 | GSK2578215A | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | GSK2606414 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | GSK2636771 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | GSK269962A | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | GSK343 | GDSC2 | 0.0010 | 1.0000 |
|
| MHH-CALL-4 | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | GSK461364 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | GSK591 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | GW-405833 | CTRP2 | 0.0041 | 130.0000 |
|
| MHH-CALL-4 | GW441756 | GDSC2 | 0.0020 | 2.0000 |
|
| MHH-CALL-4 | GW843682X | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | HC-067047 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | HLI 373 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | hyperforin | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | I-BET-762 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | I-BET151 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | I-BRD9 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | Ibrutinib | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | IC-87114 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Idelalisib | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | ifosfamide | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Imatinib | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | importazole | CTRP2 | 0.0061 | 200.0000 |
|
| MHH-CALL-4 | indisulam | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | IOX2 | GDSC2 | 0.0005 | 0.5000 |
|
| MHH-CALL-4 | Ipatasertib | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Irinotecan | GDSC2 | 0.0050 | 5.0000 |
|
| MHH-CALL-4 | isoevodiamine | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | isonicotinohydroxamic acid | CTRP2 | 0.0020 | 33.0000 |
|
| MHH-CALL-4 | ISOX | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | ISOX:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| MHH-CALL-4 | itraconazole | CTRP2 | 0.0005 | 17.0000 |
|
| MHH-CALL-4 | IU1 | CTRP2 | 0.0020 | 33.0000 |
|
| MHH-CALL-4 | IWP-2 | GDSC2 | 0.0010 | 1.0000 |
|
| MHH-CALL-4 | JNK Inhibitor VIII | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | JQ-1:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | JQ-1:MK-0752 (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MHH-CALL-4 | JQ-1:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MHH-CALL-4 | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MHH-CALL-4 | JQ1 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | JW-480 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | JW-55 | CTRP2 | 0.0020 | 33.0000 |
|
| MHH-CALL-4 | JW-74 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | KH-CB19 | CTRP2 | 0.0005 | 17.0000 |
|
| MHH-CALL-4 | KHS101 | CTRP2 | 0.0041 | 66.0000 |
|
| MHH-CALL-4 | Ki8751 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Ko-143 | CTRP2 | 0.0041 | 130.0000 |
|
| MHH-CALL-4 | KPT185 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | KRAS (G12C) Inhibitor-12 | GDSC2 | 0.0200 | 20.0000 |
|
| MHH-CALL-4 | KU 0060648 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | KU-0063794 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | KU-55933 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | KU-60019 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | L-685458 | CTRP2 | 0.0011 | 37.0000 |
|
| MHH-CALL-4 | Lapatinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | LBH-589 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | LCL161 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | LE-135 | CTRP2 | 0.0020 | 4.2000 |
|
| MHH-CALL-4 | Leflunomide | GDSC2 | 0.1001 | 100.0000 |
|
| MHH-CALL-4 | Lenalidomide | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Lestaurtinib | GDSC2 | 0.0020 | 2.0000 |
|
| MHH-CALL-4 | LGK974 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | Linifanib | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Linsitinib | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | LJI308 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | lovastatin acid | CTRP2 | 0.0041 | 130.0000 |
|
| MHH-CALL-4 | LRRK2-IN-1 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Luminespib | GDSC2 | 0.0003 | 0.2500 |
|
| MHH-CALL-4 | LY-2183240 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | LY2109761 | GDSC2 | 0.0050 | 5.0000 |
|
| MHH-CALL-4 | manumycin A | CTRP2 | 0.0009 | 30.0000 |
|
| MHH-CALL-4 | Masitinib | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Mdivi-1 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Merck60 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | Methotrexate | GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| MHH-CALL-4 | methylstat | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | MG-132 | GDSC2 | 0.0040 | 4.0000 |
|
| MHH-CALL-4 | MGCD-265 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | MI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | MIRA-1 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Mirin | GDSC2 | 0.1001 | 100.0000 |
|
| MHH-CALL-4 | mitomycin | CTRP2 | 0.0015 | 50.0000 |
|
| MHH-CALL-4 | MK-0752 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | MK-1775 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | MK-2206 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | MK-8776 | GDSC2 | 0.0050 | 5.0000 |
|
| MHH-CALL-4 | ML006 | CTRP2 | 0.0160 | 530.0000 |
|
| MHH-CALL-4 | ML030 | CTRP2 | 0.0020 | 33.0000 |
|
| MHH-CALL-4 | ML050 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | ML162 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | ML203 | CTRP2 | 0.0011 | 37.0000 |
|
| MHH-CALL-4 | ML210 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | ML239 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | ML258 | CTRP2 | 0.0041 | 66.0000 |
|
| MHH-CALL-4 | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| MHH-CALL-4 | ML320 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | ML323 | GDSC2 | 0.0200 | 20.0000 |
|
| MHH-CALL-4 | ML334 diastereomer | CTRP2 | 0.0041 | 130.0000 |
|
| MHH-CALL-4 | MLN2238 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | MN-64 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | momelotinib | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Motesanib | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | myricetin | CTRP2 | 0.0020 | 33.0000 |
|
| MHH-CALL-4 | N9-isopropylolomoucine | CTRP2 | 0.0120 | 200.0000 |
|
| MHH-CALL-4 | nakiterpiosin | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | narciclasine | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | Navitoclax | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | navitoclax:birinapant (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | navitoclax:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | navitoclax:piperlongumine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MHH-CALL-4 | necrostatin-1 | CTRP2 | 0.0160 | 530.0000 |
|
| MHH-CALL-4 | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | necrosulfonamide | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Nelarabine | CTRP2 | 0.0020 | 33.0000 |
|
| MHH-CALL-4 | neratinib | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | niclosamide | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | Nilotinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | nintedanib | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Niraparib | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | NPC-26 | CTRP2 | 0.0012 | 40.0000 |
|
| MHH-CALL-4 | NSC 74859 | CTRP2 | 0.0160 | 530.0000 |
|
| MHH-CALL-4 | NSC23766 | CTRP2 | 0.0320 | 530.0000 |
|
| MHH-CALL-4 | NSC30930 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | NSC48300 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | NSC632839 | CTRP2 | 0.0160 | 33.0000 |
|
| MHH-CALL-4 | NSC95397 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | NU7441 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | Nutlin-3a | GDSC2,CTRP2 | 0.0045 | 150.0000 |
|
| MHH-CALL-4 | NVP-231 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | NVP-ADW742 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | NVP-TAE684 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Obatoclax Mesylate | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | OF-1 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | Olaparib | GDSC2,CTRP2 | 0.0045 | 150.0000 |
|
| MHH-CALL-4 | oligomycin A | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | omacetaxine mepesuccinate | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | OSI-027 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | OSI-930 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Osimertinib | GDSC2 | 0.0010 | 1.0000 |
|
| MHH-CALL-4 | OTX015 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| MHH-CALL-4 | Oxaliplatin | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | P22077 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | PAC-1 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | Paclitaxel | GDSC2,CTRP2 | 0.0001 | 66.0000 |
|
| MHH-CALL-4 | Palbociclib | GDSC2 | 0.0040 | 4.0000 |
|
| MHH-CALL-4 | palmostatin B | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | pandacostat | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | parbendazole | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Parthenolide | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Pazopanib | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | PCI-34051 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | PD 153035 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | PD0325901 | GDSC2 | 0.0025 | 2.5000 |
|
| MHH-CALL-4 | PD173074 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Pevonedistat | GDSC2,CTRP2 | 0.0011 | 37.0000 |
|
| MHH-CALL-4 | PF-184 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | PF-4708671 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | PF-750 | CTRP2 | 0.0081 | 130.0000 |
|
| MHH-CALL-4 | PFI-1 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | PFI3 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | PHA-793887 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | phloretin | CTRP2 | 0.0180 | 590.0000 |
|
| MHH-CALL-4 | PI-103 | CTRP2 | 0.0011 | 37.0000 |
|
| MHH-CALL-4 | Picolinici-acid | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | Pictilisib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | pifithrin-alpha | CTRP2 | 0.0071 | 230.0000 |
|
| MHH-CALL-4 | pifithrin-mu | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | PIK-93 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Piperlongumine | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | piperlongumine:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | pitstop2 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | PL-DI | CTRP2 | 0.0081 | 66.0000 |
|
| MHH-CALL-4 | Platin | CTRP2 | 0.0020 | 33.0000 |
|
| MHH-CALL-4 | pluripotin | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | PLX-4032 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | PLX-4720 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | PRIMA-1 | CTRP2 | 0.0051 | 170.0000 |
|
| MHH-CALL-4 | PRIMA-1MET | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | PRL-3 Inhibitor I | CTRP2 | 0.0041 | 130.0000 |
|
| MHH-CALL-4 | procarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | prochlorperazine | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | PRT062607 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | purmorphamine | CTRP2 | 0.0046 | 150.0000 |
|
| MHH-CALL-4 | PX-12 | CTRP2 | 0.0030 | 100.0000 |
|
| MHH-CALL-4 | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Pyridostatin | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | Quizartinib | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | R428 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | RAF265 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Rapamycin | GDSC2,CTRP2 | 0.0001 | 33.0000 |
|
| MHH-CALL-4 | Refametinib | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | Regorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Repligen 136 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | RG-108 | CTRP2 | 0.0081 | 270.0000 |
|
| MHH-CALL-4 | Ribociclib | GDSC2 | 0.0020 | 2.0000 |
|
| MHH-CALL-4 | rigosertib | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | RITA | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | RO-3306 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | Rucaparib | GDSC2 | 0.0050 | 5.0000 |
|
| MHH-CALL-4 | Ruxolitinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | RVX-208 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | Sabutoclax | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | salermide | CTRP2 | 0.0120 | 200.0000 |
|
| MHH-CALL-4 | salermide:PLX-4032 (12:1 mol-mol) | CTRP2 | 0.0066 | 220.0000 |
|
| MHH-CALL-4 | Sapitinib | GDSC2 | 0.0050 | 5.0000 |
|
| MHH-CALL-4 | Saracatinib | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Savolitinib | GDSC2 | 0.0010 | 1.0000 |
|
| MHH-CALL-4 | SB-225002 | CTRP2 | 0.0011 | 37.0000 |
|
| MHH-CALL-4 | SB-431542 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | SB216763 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | SB505124 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | SB590885 | GDSC2 | 0.0050 | 5.0000 |
|
| MHH-CALL-4 | SCH-529074 | CTRP2 | 0.0010 | 17.0000 |
|
| MHH-CALL-4 | SCH-79797 | CTRP2 | 0.0011 | 37.0000 |
|
| MHH-CALL-4 | SCH772984 | GDSC2 | 0.0050 | 5.0000 |
|
| MHH-CALL-4 | Selisistat | CTRP2 | 0.0024 | 80.0000 |
|
| MHH-CALL-4 | Selumetinib | GDSC2,CTRP2 | 0.0081 | 270.0000 |
|
| MHH-CALL-4 | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| MHH-CALL-4 | selumetinib:decitabine (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| MHH-CALL-4 | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| MHH-CALL-4 | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| MHH-CALL-4 | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| MHH-CALL-4 | selumetinib:navitoclax (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| MHH-CALL-4 | selumetinib:piperlongumine (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| MHH-CALL-4 | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| MHH-CALL-4 | selumetinib:tretinoin (2:1 mol-mol) | CTRP2 | 0.0061 | 200.0000 |
|
| MHH-CALL-4 | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| MHH-CALL-4 | selumetinib:vorinostat (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| MHH-CALL-4 | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Sepantronium bromide | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | Serdemetan | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | serdemetan:SCH-529074 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | SGC0946 | GDSC2 | 0.0005 | 0.5000 |
|
| MHH-CALL-4 | SGX-523 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | SID 26681509 | CTRP2 | 0.0360 | 300.0000 |
|
| MHH-CALL-4 | sildenafil | CTRP2 | 0.0160 | 270.0000 |
|
| MHH-CALL-4 | silmitasertib | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | simvastatin | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| MHH-CALL-4 | SJ-172550 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | SKI-II | CTRP2 | 0.0041 | 130.0000 |
|
| MHH-CALL-4 | SL0101 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | SMER-3 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | SN-38 | GDSC2,CTRP2 | 0.0000 | 10.0000 |
|
| MHH-CALL-4 | SNS-032 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | SNX-2112 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| MHH-CALL-4 | Sorafenib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | sotrastaurin | CTRP2 | 0.0320 | 66.0000 |
|
| MHH-CALL-4 | spautin-1 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Sphingosine Kinase 1 Inhibitor II | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | SR-II-138A | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | SR1001 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Staurosporine | GDSC2 | 0.0078 | 2.0000 |
|
| MHH-CALL-4 | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | STF-31 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | SU11274 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Sunitinib | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | T-5345967 | CTRP2 | 0.0160 | 530.0000 |
|
| MHH-CALL-4 | tacedinaline | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | tacrolimus | CTRP2 | 0.0023 | 74.0000 |
|
| MHH-CALL-4 | Talazoparib | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | tamatinib | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | Tamoxifen | GDSC2,CTRP2 | 0.0030 | 100.0000 |
|
| MHH-CALL-4 | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Tanespimycin | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | tanespimycin:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| MHH-CALL-4 | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | Taselisib | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | Telomerase Inhibitor IX | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | Temozolomide | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Temsirolimus | GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| MHH-CALL-4 | Teniposide | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | TG-100-115 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | TGX221 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | tigecycline | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | tipifarnib-P1 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | tipifarnib-P2 | CTRP2 | 0.0160 | 33.0000 |
|
| MHH-CALL-4 | Tivozanib | CTRP2 | 0.0020 | 33.0000 |
|
| MHH-CALL-4 | Topotecan | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | tosedostat | CTRP2 | 0.0081 | 270.0000 |
|
| MHH-CALL-4 | Tozasertib | GDSC2 | 0.0050 | 5.0000 |
|
| MHH-CALL-4 | TPCA-1 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Trametinib | GDSC2 | 0.0010 | 1.0000 |
|
| MHH-CALL-4 | Tretinoin | GDSC2,CTRP2 | 0.0041 | 130.0000 |
|
| MHH-CALL-4 | tretinoin:carboplatin (2:1 mol-mol) | CTRP2 | 0.0030 | 100.0000 |
|
| MHH-CALL-4 | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 |
|
| MHH-CALL-4 | trifluoperazine | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | triptolide | CTRP2 | 0.0000 | 0.2900 |
|
| MHH-CALL-4 | Tubastatin A | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | TW 37 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | Ulixertinib | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | UNC0321 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | UNC0638 | CTRP2 | 0.0010 | 17.0000 |
|
| MHH-CALL-4 | UNC0638:navitoclax (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | Uprosertib | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | VAF-347 | CTRP2 | 0.0020 | 33.0000 |
|
| MHH-CALL-4 | valdecoxib | CTRP2 | 0.0180 | 600.0000 |
|
| MHH-CALL-4 | vandetanib | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | VE-822 | GDSC2 | 0.0050 | 5.0000 |
|
| MHH-CALL-4 | VE821 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | Veliparib | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | Venetoclax | GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| MHH-CALL-4 | VER-155008 | CTRP2 | 0.0011 | 37.0000 |
|
| MHH-CALL-4 | Vincristine | CTRP2 | 0.0041 | 130.0000 |
|
| MHH-CALL-4 | Vinorelbine | GDSC2 | 0.0001 | 0.1000 |
|
| MHH-CALL-4 | Vismodegib | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | vorapaxar | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Vorinostat | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | VX-11e | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | WAY-362450 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | Wee1 Inhibitor | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | WEHI-539 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | WIKI4 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | Wnt-C59 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | WZ4002 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | WZ4003 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | WZ8040 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | XAV939 | GDSC2 | 0.0050 | 5.0000 |
|
| MHH-CALL-4 | XL765 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | YK-4-279 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| MHH-CALL-4 | YL54 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-CALL-4 | zebularine | CTRP2 | 0.0180 | 590.0000 |
|
| MHH-CALL-4 | ZM447439 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-CALL-4 | ZSTK474 | CTRP2 | 0.0020 | 66.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC